市場調查報告書
商品編碼
1471038
放射腫瘤學市場:按產品、技術、應用和最終用戶分類 - 2024-2030 年全球預測Radiation Oncology Market by Product (Hardware, Services, Software), Technology (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年放射腫瘤學市場規模為135.9億美元,預計2024年將達145.6億美元,2030年將達222.3億美元,複合年成長率為7.28%。
放射腫瘤學專注於在癌症治療中使用電離輻射。透過精確地照射放射線,可以瞄準並去除癌細胞或抑制其發展。放射線治療是癌症治療的重要組成部分,可以作為單一療法或與化療和其他治療方法合併使用。放射腫瘤學隨著技術進步和治療技術不斷發展,實現更精確、更有效的癌症治療。放射腫瘤學市場的成長要素包括全球癌症發生率的增加、放射治療技術的進步以及對非侵入性治療方法的需求不斷增加。然而,放射線治療和相關設備的高成本以及熟練專業人員的缺乏給市場帶來了重大挑戰。政府企業和癌症治療研發投資的增加、放射腫瘤治療的進步提高了治療的安全性,正在為放射腫瘤市場創造利潤豐厚的機會。
主要市場統計 | |
---|---|
基準年[2023] | 135.9億美元 |
預測年份 [2024] | 145.6億美元 |
預測年份 [2030] | 222.3億美元 |
複合年成長率(%) | 7.28% |
產品放射腫瘤學硬體的顯著普及
放射腫瘤學硬體包括用於透過放射線治療治療癌症的物理設備和機器。我們的主要硬體產品包括線性加速器(直線加速器)、質子治療系統以及整合到 CT、MRI 和 PET 掃描儀等放射治療設備中的影像設備。這些設備對於向腫瘤部位提供精確劑量的輻射,同時最大限度地減少對周圍健康組織的暴露至關重要。放射腫瘤學服務包括高效系統運作、患者照護和臨床結果所需的廣泛支持。這包括腫瘤硬體安裝、維護和維修、醫療專業人員培訓、治療計劃諮詢服務以及放射治療設施營運管理。它還包括先進的治療計劃支援、劑量測定服務和患者支援計劃,以確保工作流程最佳化和改善患者照護。放射腫瘤學軟體對於臨床醫生製定和提供有效的治療計劃至關重要。此軟體類別包括治療計劃系統 (TPS)、文件和檢驗系統、劑量管理平台和資料分析工具。現代治療計劃系統是複雜的工具,可以實現複雜的劑量計算、劑量分佈的 3D 可視化以及與成像軟體整合以實現精確的腫瘤靶向。此外,腫瘤資訊系統 (OIS) 對於管理患者資訊和工作流程至關重要。
技術:利用外束放射治療最大限度地減少健康組織的輻射暴露並改善患者的治療效果
外部放射治療是一種主要的癌症治療方法,它使用高能量束從體外靶向腫瘤。 EBRT 的先進技術旨在提高準確性、最大限度地減少健康組織的輻射暴露並改善患者的治療效果。緊湊型先進放射治療系統代表了 EBRT 的一類,其設計比傳統選擇更節省空間且資源集中更少。 電腦刀系統是一種非侵入性放射治療選項,使用機械臂提供高度聚焦的放射束。此系統精度很高,可以以亞毫米精度治療身體任何部位的腫瘤。伽瑪刀技術是一種立體定位放射線手術(SRS)技術,旨在治療腦部疾病。斷層放射治療強度調控放射治療(IMRT) 與電腦斷層掃描 (CT) 影像結合,以實現精確治療。線性加速器是現代放射治療的基礎,產生高能量 X 光和電子束來治療多種癌症。質子療法是一種先進的放射療法,使用質子而不是 X光。迴旋加速器是質子治療中使用的粒子加速器,可將質子束加速到高能量,然後照射到患者體內。同步加速器是質子治療中使用的另一種形式的粒子加速器。它可以將質子加速到比迴旋加速器更高的能量,這對於治療深部腫瘤至關重要。內束放射線治療是治療方法。施用器是一種設計用於固定放射源並將其精確放置在治療區域的裝置。它們有不同的形狀和尺寸,以適應特定的解剖區域,如子宮頸、前列腺、乳房和皮膚。後荷機是一種複雜的機器,可將放射源輸送到已連接到患者身上的施用器上。電近距離放射治療是近距離放射治療的一種型態,其中小型 X光源提供輻射而不是放射性同位素。種子是用於近距離放射治療的小型放射性顆粒,特別是用於前列腺癌。全身放射線治療,也稱為放射性同位素治療,使用進入血液並殺死癌細胞的放射性藥物。
應用:放射腫瘤學在乳癌治療的重要性
對於某些類型的血癌,例如淋巴瘤和某些白血病,放射線治療可用於破壞癌細胞或緩解淋巴結腫大或腫瘤引起的症狀。可以對癌細胞集中的身體特定區域進行放射治療,稱為放射治療。它也可以用作幹細胞移植前調理方案的一部分。放射線治療用於治療乳房保留手術(腫塊切除術)後的乳癌,以降低復發風險。如果腫瘤很大或癌症擴散到淋巴結,也可以在切除術使用。此外,強度調控放射治療(IMRT) 等先進技術可實現高精度標靶照射,最大限度地減少對周圍健康組織的損害。胃腸道癌症,如胃癌、結腸癌、直腸癌和胰腺癌,需要放射線治療。例如,對於直腸癌,術前放射線治療治療合併化療是縮小腫瘤並使腫瘤更容易手術切除的標準。放射線治療在局部和進行性前列腺癌中都發揮著重要作用。對於早期前列腺癌,它被用作外束放射治療或近距離放射治療的主要治療方法。它還可能針對已轉移到骨骼或其他器官的癌症,緩解症狀並改善治療結果。在肺癌的治療中,放射腫瘤學技術,包括立體定位放射線治療(SBRT),提供了一種高效、非侵入性的選擇,可以破壞不適合手術的患者的癌細胞。此外,放射線治療可作為手術的輔助療法,或與局部晚期或轉移性疾病的化療合併使用,以減輕症狀並延長存活期。放射線治療是治療非黑色素瘤皮膚癌的一種有價值的治療方法,特別是當腫瘤太大、太深或位於難以透過手術治療的區域時。不穿經皮膚的電子束療法特別有用。對於黑色素瘤,放射線不是主要治療方法,但可用於治療轉移性腫瘤或作為手術切除後的輔助性治療。
最終使用者:放射腫瘤學在提供綜合癌症治療的醫院部門中的潛在用途
提供放射線治療的醫院通常是提供全面癌症治療的大型設施。患者通常更喜歡醫院,因為它們提供全面的醫療服務,包括外科手術、化療、復健服務和放射治療。需要多學科方法的複雜癌症治療更有可能有利於醫院。獨立放射治療中心是專門從事放射治療服務的專門機構。這些中心是尋求治療方法容易獲得且可以更快開始治療的患者的首選。此外,患者體驗通常比醫院護理更加個人化。
區域洞察
由於高額醫療保健支出、先進的醫療保健基礎設施和強大的技術創新管道,美洲的放射腫瘤學市場正在成長。人口老化加劇、癌症發病率上升以及完善的報銷制度使得該地區更容易獲得放射治療。由於設施分散以及對腫瘤學研究和開發的興趣日益濃厚,歐盟 (EU) 對 KEYWORD 服務的需求量很大。中東和非洲的放射腫瘤學市場受到醫療保健基礎設施投資增加、先進技術採用增加以及採購新一代設備的新癌症治療設施的影響。政府對醫療保健基礎設施的投資和癌症發病率的上升以及對本地設備製造的重視都表明亞太地區放射腫瘤學市場的顯著成長。
FPNV定位矩陣
FPNV定位矩陣對於評估放射腫瘤學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對放射腫瘤學市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1. 放射腫瘤市場的市場規模與預測是多少?
2.在放射腫瘤學市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3. 放射腫瘤學市場的技術趨勢和法規結構是什麼?
4.放射腫瘤學市場主要供應商的市場佔有率為何?
5. 進入放射腫瘤市場的合適型態和策略手段是什麼?
[191 Pages Report] The Radiation Oncology Market size was estimated at USD 13.59 billion in 2023 and expected to reach USD 14.56 billion in 2024, at a CAGR 7.28% to reach USD 22.23 billion by 2030.
Radiation oncology focuses on the use of ionizing radiation in the treatment of cancer. It involves the precise delivery of radiation to target and eliminate cancer cells or inhibit their development. Radiation therapy is a critical element of cancer treatment and can be used as a standalone therapy or in combination with chemotherapy and other therapeutic modalities. Radiation oncology continually evolves with technological advancements and treatment techniques, allowing for more precise and effective cancer care. Factors contributing to the growth of the radiation oncology market include the increasing global prevalence of cancer, advancements in radiation therapy technologies, and the rising demand for non-invasive treatment modalities. However, the high costs associated with radiation therapy and related instruments and a lack of skilled professionals pose a significant challenge to the market. Rising government enterprises and investments in R&D in the treatment of cancer treatments and advances in radiation oncology treatment to improve treatment safety create a lucrative opportunity for the radiation oncology market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 13.59 billion |
Estimated Year [2024] | USD 14.56 billion |
Forecast Year [2030] | USD 22.23 billion |
CAGR (%) | 7.28% |
Product: Significant penetration of radiation oncology hardware
Radiation oncology hardware encompasses the physical devices and machines used to treat cancer through radiation therapy. Key hardware products include linear accelerators (LINACs), proton therapy systems, and imaging devices incorporated into radiotherapy equipment such as CT, MRI, and PET scanners. This equipment is integral in delivering precise doses of radiation to tumor sites while minimizing exposure to surrounding healthy tissues. Services in radiation oncology involve the spectrum of support required for efficient system operation, patient care, and clinical outcomes. This includes installation, maintenance, and repair of oncology hardware; training for medical professionals; consultation services for treatment planning; and operational management of radiation therapy facilities. Additionally, services may also encompass advanced treatment planning support, dosimetry services, and patient support programs that ensure optimized workflows and enhanced patient care. Radiation oncology software is crucial for clinicians to design and deliver effective treatment plans. This software category includes treatment planning systems (TPS), record and verify systems, dose management platforms, and data analytics tools. Contemporary treatment planning systems are sophisticated tools that allow for the intricacies of dosimetric calculation, 3D visualization of dose distribution, and integration with imaging software to target tumors precisely. Furthermore, oncology information systems (OIS) are essential for managing patient information and workflow in a radiation oncology department.
Technology: Utilization of external beam radiation therapy to minimize exposure to healthy tissues and improve patient outcomes
External beam radiation therapy is a principal modality for treating cancer, utilizing high-energy beams to target tumors from outside the body. Advanced technologies in EBRT aim to enhance precision, minimize exposure to healthy tissues, and improve patient outcomes. Compact advanced radiotherapy systems represent a category of EBRT designed to be space-efficient and less resource-intensive than traditional options. The CyberKnife system is a non-invasive option for radiotherapy that uses a robotic arm to deliver highly focused radiation beams. The system's precision allows for treating tumors in any portion of the body with sub-millimeter accuracy. Gamma knife technology is a stereotactic radiosurgery (SRS) designed to treat brain disorders. Tomotherapy integrates intensity-modulated radiation therapy (IMRT) with computed tomography (CT) imaging for precise treatment delivery. Linear accelerators are the cornerstone of modern radiation therapy, producing high-energy X-rays or electrons for treating various cancers. Proton therapy is an evolved state of radiation treatment that uses protons rather than X-rays. A cyclotron is a particle accelerator used in proton therapy that accelerates protons to high energies before they are directed into the patient's body. Synchrotrons are another form of particle accelerator utilized in proton therapy. They can accelerate protons to even higher energies than cyclotrons, essential for treating deep-seated tumors. Internal beam radiation therapy is a procedure that involves placing radioactive material inside or very close to the tumor. Applicators are devices designed to hold radioactive sources and position them precisely at the treatment site. They come in various shapes and sizes, tailored to the specific anatomical site, such as the cervix, prostate, breast, or skin. Afterloaders are sophisticated machines that deliver the radioactive source into the applicator already placed in the patient. Electronic brachytherapy is a form of brachytherapy where a miniaturized X-ray source delivers radiation instead of radioactive isotopes. Seeds are tiny radioactive pellets used in brachytherapy, particularly for prostate cancer. Systemic radiation therapy also referred to as radioisotope therapy, involves the use of radioactive drugs, or radiopharmaceuticals, which travel through the bloodstream to target and kill cancer cells.
Application: Significant emphasis on radiation oncology for breast cancer treatment
For certain types of blood cancer, such as lymphomas or specific leukemias, radiation therapy can be used to destroy cancer cells or to alleviate symptoms caused by enlarged lymph nodes or tumors. Radiation may be directed to specific areas of the body with a concentration of cancer cells, which is known as involved field radiation, or it can be used as part of a conditioning regimen before a stem cell transplant. Radiation therapy is used in the treatment of breast cancer after breast-conserving surgery (lumpectomy) to reduce the risk of recurrence. It may also be applied after mastectomy in cases with larger tumors or when cancer has spread to lymph nodes. Additionally, advanced techniques such as intensity-modulated radiation therapy (IMRT) allow high-precision targeting, minimizing damage to surrounding healthy tissues. Gastrointestinal cancers, including those of the stomach, colon, rectum, and pancreas, require radiation therapy. In rectal cancer, for example, preoperative radiation combined with chemotherapy is the standard to reduce tumor size, making it more amenable to surgical removal. Radiation therapy plays a key role in localized and advanced prostate cancer. For early-stage prostate cancer, it can be used as a primary treatment through external beam radiation or brachytherapy. It may also target cancer that has spread to the bones or other organs, providing symptom relief and improving the treatment outcome. In the treatment of lung cancer, radiation oncology techniques, including stereotactic body radiation therapy (SBRT), offer a highly effective, non-invasive option for destroying tumor cells in patients that may not be candidates for surgery. Additionally, radiation may be employed as an adjunct to surgery or combined with chemotherapy in locally advanced or metastatic cases to alleviate symptoms and extend survival. Radiation therapy serves as a valuable treatment for non-melanoma skin cancers, particularly for tumors that are too large, too deep, or located in areas difficult to treat with surgery. Electron beam therapy, which does not penetrate beyond the skin, is particularly useful. For melanomas, radiation may not be a primary treatment; however, it can be used to treat metastases or as adjuvant therapy after surgical removal of the cancer.
End-User: Potential use of radiation oncology in hospital sectors to provide comprehensive cancer care
Hospitals offering radiation therapy are typically large-scale facilities that provide comprehensive cancer care. Patients often prefer hospitals due to the integrated medical services they offer, which could include surgical procedures, chemotherapy, rehabilitation services, and radiotherapy. The preference for hospitals is heightened in complex cancer treatments requiring a multidisciplinary approach. Independent radiotherapy centers are specialized facilities dedicated solely to providing radiotherapy services. These centers are preferred by patients seeking treatment options that are more accessible and may offer a quicker initiation of therapy. Additionally, the patient experience is often more personalized than in hospital settings.
Regional Insights
The radiation oncology market is growing in the Americas due to high healthcare expenditure, advanced healthcare infrastructure, and a robust pipeline of technological innovations. The rising aging population, rising cancer prevalence, and a well-established reimbursement system facilitate access to radiation therapy in the region. The European Union exhibits a strong demand for radiation oncology services with a well-distributed network of facilities and a growing interest in oncology research and development. The Middle East and Africa's radiation oncology market is influenced by growing investment in healthcare infrastructure, an increasing adoption of advanced technologies, and the establishment of new cancer treatment facilities procuring new-generation equipment. Governmental investments in healthcare infrastructure and a rising incidence of cancer emphasis on local equipment manufacturing demonstrate significant growth of the radiation oncology market in the APAC region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Radiation Oncology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radiation Oncology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Radiation Oncology Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Becton, Dickinson and Company, Bionix LLC, BrainLab AG, Canon Inc., Carl Zeiss AG, Curium SAS, Eckert and Ziegler AG, Elekta AB, GE HealthCare Technologies Inc., Hitachi, LTD., Hologic, Inc., IntraOp Medical, Inc., Ion Beam Applications S.A., Isoray Inc., Koninklijke Philips N.V., Nordion Inc., Optivus Proton Therapy, Inc., P-Cure LTD., Panacea Medical Technologies Pvt. LTD., Provision Healthcare, LLC., Stryker Corporation, Sumitomo Heavy Industries, LTD, Theragenics Corporation, Varian Medical Systems by Siemens Healthineers, and ViewRay, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Radiation Oncology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radiation Oncology Market?
3. What are the technology trends and regulatory frameworks in the Radiation Oncology Market?
4. What is the market share of the leading vendors in the Radiation Oncology Market?
5. Which modes and strategic moves are suitable for entering the Radiation Oncology Market?